CXCL12 and neoplasm: In another study, kisspeptin treatment inhibited cancer cell migration in a PKC-dependent manner (67), and decreased stromal cell-derived factor 1 (SDF-1) mediated tumor migration by suppressing AKT phosphorylation (63).